GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai MicroPort MedBot (Group) Co Ltd (HKSE:02252) » Definitions » ROE %

Shanghai MicroPort MedBot (Group) Co (HKSE:02252) ROE % : -128.53% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai MicroPort MedBot (Group) Co ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Shanghai MicroPort MedBot (Group) Co's annualized net income for the quarter that ended in Dec. 2023 was HK$-1,035.1 Mil. Shanghai MicroPort MedBot (Group) Co's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was HK$805.3 Mil. Therefore, Shanghai MicroPort MedBot (Group) Co's annualized ROE % for the quarter that ended in Dec. 2023 was -128.53%.

The historical rank and industry rank for Shanghai MicroPort MedBot (Group) Co's ROE % or its related term are showing as below:

HKSE:02252' s ROE % Range Over the Past 10 Years
Min: -264.29   Med: -56.4   Max: -28.46
Current: -103.99

During the past 5 years, Shanghai MicroPort MedBot (Group) Co's highest ROE % was -28.46%. The lowest was -264.29%. And the median was -56.40%.

HKSE:02252's ROE % is ranked worse than
87.42% of 803 companies
in the Medical Devices & Instruments industry
Industry Median: -0.16 vs HKSE:02252: -103.99

Shanghai MicroPort MedBot (Group) Co ROE % Historical Data

The historical data trend for Shanghai MicroPort MedBot (Group) Co's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai MicroPort MedBot (Group) Co ROE % Chart

Shanghai MicroPort MedBot (Group) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
-264.29 -28.46 -30.76 -56.40 -102.92

Shanghai MicroPort MedBot (Group) Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only -37.46 -40.88 -77.61 -89.82 -128.53

Competitive Comparison of Shanghai MicroPort MedBot (Group) Co's ROE %

For the Medical Devices subindustry, Shanghai MicroPort MedBot (Group) Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai MicroPort MedBot (Group) Co's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort MedBot (Group) Co's ROE % distribution charts can be found below:

* The bar in red indicates where Shanghai MicroPort MedBot (Group) Co's ROE % falls into.



Shanghai MicroPort MedBot (Group) Co ROE % Calculation

Shanghai MicroPort MedBot (Group) Co's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-1107.095/( (1583.12+568.196)/ 2 )
=-1107.095/1075.658
=-102.92 %

Shanghai MicroPort MedBot (Group) Co's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-1035.07/( (1042.473+568.196)/ 2 )
=-1035.07/805.3345
=-128.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Shanghai MicroPort MedBot (Group) Co  (HKSE:02252) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-1035.07/805.3345
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1035.07 / 124.666)*(124.666 / 1734.694)*(1734.694 / 805.3345)
=Net Margin %*Asset Turnover*Equity Multiplier
=-830.27 %*0.0719*2.154
=ROA %*Equity Multiplier
=-59.7 %*2.154
=-128.53 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-1035.07/805.3345
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1035.07 / -1047.396) * (-1047.396 / -906.978) * (-906.978 / 124.666) * (124.666 / 1734.694) * (1734.694 / 805.3345)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9882 * 1.1548 * -727.53 % * 0.0719 * 2.154
=-128.53 %

Note: The net income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Shanghai MicroPort MedBot (Group) Co ROE % Related Terms

Thank you for viewing the detailed overview of Shanghai MicroPort MedBot (Group) Co's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Business Description

Traded in Other Exchanges
N/A
Address
1601 Zhangdong Road, Room 101, Area B, Building 1, Pilot Free Trade Zone, Shanghai, CHN
Shanghai MicroPort MedBot (Group) Co Ltd is a top-tier surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures.
Executives
He Chao 2201 Interest of corporation controlled by you
Yuan Shuai 2201 Interest of corporation controlled by you
Ji Shufang 2202 Interest of your spouse
Wu Kaili 2202 Interest of your spouse
Shenzhen Gao Ling Tiancheng Phase Iii Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shenzhen Gao Ling Muqi Equity Investment Fund Llp 2201 Interest of corporation controlled by you
Xiamen Gao Ling Ruiqi Equity Investment Fund Llp 2201 Interest of corporation controlled by you
Zhuhai Gao Ling Chongheng Equity Investment Llp 2101 Beneficial owner
Shang Hai Wei Chuang Tou Zi Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Qing Zhen Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo 2103 Interests held jointly with another person
Shang Hai Mo Hua Ren Gong Zhi Neng Ke Ji You Xian Gong Si 2103 Interests held jointly with another person
Wei Chuang Yi Liao Ke Xue You Xian Gong Si 2201 Interest of corporation controlled by you
Shang Hai Qing Min Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo 2101 Beneficial owner

Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Headlines

No Headlines